Priscila Radu

Priscila has published research on various health economics topics, including changes in HTA methods in several regions, assessment pathways for precision oncology, and regulatory landscape of digital health in the UK. She is interested in effective administration of public funds for healthcare, specifically in LMICs.

Priscila is a recipient of the fully-funded OHE scholarship for Health Economics, having passed her Master’s degree in Health Economics with Distinction. She received the Best Dissertation award for her work on the economic evaluation of Next-generation sequencing for lung cancer. Priscila has previously worked in healthcare communications and public relations where she provided strategic advice to clients on corporate communications, media and stakeholder engagement.